Position in DHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$464,771
+$221,894 QoQ
Shares Held
2,440
+90.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,397
of 2,105 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Headlands Technologies LLC holds $7,069,211 across 9 Diagnostics & Research names. DHR ranks #4 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,280 | $3,148,540 | |
| 2 | NTRA |
Natera, Inc.
|
5,102 | $1,384,937 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,133 | $1,122,896 | |
| 4 | DHR |
Danaher Corp /De/
This page
|
2,440 | $464,771 | |
| 5 | RVTY |
Revvity, Inc.
|
3,330 | $370,495 | |
| 6 | FLGT |
Fulgent Genetics, Inc.
|
17,453 | $358,135 | |
| 7 | OPK |
Opko Health, Inc.
|
107,989 | $161,983 | |
| 8 | MYGN |
Myriad Genetics Inc
|
10,062 | $57,454 |
All Filings in DHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $464,771 | 2,440 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $242,877 | 1,281 | Shares | Sole | 2026-05-13 | |
| 2025-06-30 | $13,710,461 | 69,406 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,201,200 | 54,640 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $9,600,699 | 41,824 | Shares | Sole | 2025-02-12 | |
| 2024-03-31 | $2,529,663 | 10,130 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $697,258 | 3,014 | Shares | Sole | 2024-02-02 | |
| 2023-06-30 | $1,888,800 | 7,870 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $611,448 | 2,426 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $1,053,186 | 3,968 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||